CVS Health Corporation (CVS)
NYSE$67.91
Market Cap
$85.62B
Sector
Healthcare
Industry
Medical—Healthcare Plans
Rank in Sector
97 of 924
Rank in Industry
3 of 11
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
CVS Insider Trading Activity
CVS Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $2,555,173 | 3 | 75 |
Sells | $498,488 | 1 | 25 |
Related Transactions
| Mahoney Michael F | director | 2 | $2.5M | 0 | $0 | $2.5M |
| LUDWIG EDWARD J | director | 1 | $53,879 | 0 | $0 | $53,879 |
| Clark James David | SVP, Cont & Chief Acct Officer | 0 | $0 | 1 | $498,488 | $-498,488 |
About CVS Health Corporation
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary …
Insider Activity of CVS Health Corporation
Over the last 12 months, insiders at CVS Health Corporation have bought $2.56M and sold $498,488 worth of CVS Health Corporation stock.
On average, over the past 5 years, insiders at CVS Health Corporation have bought $1.33M and sold $43.6M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mahoney Michael F (director) — $2.5M. LUDWIG EDWARD J (director) — $53,879.
The last purchase of 30,000 shares for transaction amount of $2M was made by Mahoney Michael F (director) on 2025‑02‑18.
List of Insider Buy and Sell Transactions, CVS Health Corporation
| 2025-03-05 | Sale | Clark James David | SVP, Cont & Chief Acct Officer | 7,513 0.0006% | $66.35 | $498,488 | -0.35% | |
| 2025-02-18 | Mahoney Michael F | director | 30,000 0.0024% | $66.70 | $2M | -0.26% | ||
| 2024-05-02 | LUDWIG EDWARD J | director | 1,000 <0.0001% | $53.88 | $53,879 | +6.01% | ||
| 2024-05-02 | Mahoney Michael F | director | 9,181 0.0007% | $54.49 | $500,294 | +6.01% | ||
| 2024-02-16 | Sale | Shah Prem S | EVP and Pres-Pharm, Consumer W | 29,473 0.0023% | $76.95 | $2.27M | -22.76% | |
| 2023-11-03 | LUDWIG EDWARD J | director | 2,000 0.0002% | $70.47 | $140,930 | -4.46% | ||
| 2023-08-03 | Sale | Clark James David | SVP, Cont & Chief Acct Officer | 25,759.26 0.002% | $74.92 | $1.93M | -5.57% | |
| 2023-05-03 | Lynch Karen S | President and CEO | 14,000 0.0011% | $69.75 | $976,567 | +2.40% | ||
| 2022-12-15 | Sale | Moriarty Thomas M | EVP & General Counsel | 36,490 0.0028% | $98.24 | $3.58M | -24.77% | |
| 2022-08-03 | Sale | Lotvin Alan | EVP&President-PharmacyServices | 70,398 0.0052% | $98.00 | $6.9M | -12.70% | |
| 2022-08-03 | Sale | Finke Daniel P | EVP/Pres, Health Care Benefits | 9,546 0.0007% | $100.00 | $954,600 | -12.70% | |
| 2022-06-28 | Sale | Moriarty Thomas M | EVP & General Counsel | 50,502 0.0039% | $95.00 | $4.8M | -1.22% | |
| 2022-04-08 | Sale | Shah Prem S | EVP and Co-President of Retail | 5,719 0.0004% | $105.00 | $600,495 | -9.76% | |
| 2022-04-04 | Sale | Finke Daniel P | EVP/Pres, Health Care Benefits | 16,161 0.0012% | $100.13 | $1.62M | -3.64% | |
| 2022-03-30 | Sale | Shah Prem S | EVP and Co-President of Retail | 5,346 0.0004% | $104.70 | $559,726 | -6.88% | |
| 2022-03-17 | Sale | Shah Prem S | EVP and Co-President of Retail | 2,935 0.0002% | $106.65 | $313,018 | -10.71% | |
| 2022-03-15 | Sale | Moriarty Thomas M | EVP & General Counsel | 51,361 0.0038% | $105.00 | $5.39M | -9.33% | |
| 2022-02-10 | LUDWIG EDWARD J | director | 1,000 <0.0001% | $105.90 | $105,904 | -5.99% | ||
| 2022-02-03 | Sale | Brennan Troyen A | EVP and Chief Medical Officer | 47,937 0.0037% | $110.00 | $5.27M | -8.69% | |
| 2022-02-01 | Sale | Lotvin Alan | EVP&President-PharmacyServices | 21,386 0.0016% | $106.50 | $2.28M | -6.46% |
Total: 316
*Gray background shows transactions not older than one year
Insider Historical Profitability
9.92%
| Mahoney Michael F | director | 39356 0.0031% | $2.67M | 2 | 0 | |
| LUDWIG EDWARD J | director | 21630 0.0017% | $1.47M | 7 | 0 | +9% |
| RYAN THOMAS M | Non-Executive Chairman | 764683 0.0607% | $51.93M | 2 | 20 | +6.96% |
| Moriarty Thomas M | EVP & General Counsel | 608129 0.0482% | $41.3M | 1 | 9 | +14.92% |
| Lynch Karen S | President and CEO | 431392 0.0342% | $29.3M | 1 | 1 | +2.4% |
*Gray background shows insiders who have made transactions during last year
CVS Institutional Investors: Active Positions
| Increased Positions | 603 | +21.64% | 123M | +12.02% |
| Decreased Positions | 1,325 | -47.54% | 92M | -9.06% |
| New Positions | 221 | New | 23M | New |
| Sold Out Positions | 379 | Sold Out | 15M | Sold Out |
| Total Postitions | 2,065 | -25.91% | 1B | +2.96% |
CVS Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $7.71M | 9.31% | 117.37M | -250,065 | -0.21% | 2024-12-31 |
| Blackrock, Inc. | $6.96M | 8.4% | 105.97M | +1M | +1.35% | 2024-12-31 |
| Dodge & Cox | $4.6M | 5.56% | 70.11M | +7M | +11.22% | 2024-12-31 |
| Capital World Investors | $4.01M | 4.84% | 61.04M | +13M | +26.58% | 2024-12-31 |
| State Street Corp | $3.74M | 4.52% | 56.95M | +425,050 | +0.75% | 2024-12-31 |
| Fmr Llc | $1.85M | 2.23% | 28.13M | -193,991 | -0.69% | 2024-12-31 |
| Geode Capital Management, Llc | $1.78M | 2.15% | 27.05M | +689,867 | +2.62% | 2024-12-31 |
| Capital International Investors | $1.75M | 2.12% | 26.67M | +1M | +4.76% | 2024-12-31 |
| Pzena Investment Management Llc | $1.29M | 1.56% | 19.61M | +6M | +49.3% | 2024-12-31 |
| Norges Bank | $1.23M | 1.48% | 18.7M | +4M | +25.51% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.